Introduction
Today we would talk about Akums Drugs and Pharmaceuticals Limited IPO, especially one of the best name in pharmaceutical manufacturing industries named as “Akum.s” which is going through upcoming its major which has catch significant for it’s own Initial Public Offering (IPO). Being one of the well known pharmaceutical contract manufacturer in India, Akums has focused on such services that helps to acquire a stronger position. In this report, we will discuss the Akums Drugs and Pharmaceuticals Limited IPO Review along with an in-depth analysis of 5 factors such as barter background, trading model performance, market strength or risk factor & assessment prospects.
Company Overview
About Akums Drugs and Pharmaceuticals Limited IPO
Akums Drugs and Pharmaceuticals Limited IPO was incepted in the year 2004 by Sandeep Jain and Sanjeev Jain with a vision of establishing a world class pharma formulation manufacturing company. Akums Drugs and Pharmaceuticals Limited IPO is a relatively old company that has also increased its capacity and site area as well as the types of products during operation. Due to its constant emphasis on the provision of quality products and setting up of other innovations, it has become the first chemical company of choice to several other renowned pharmaceutical firms in the country and beyond. Akums Drugs and Pharmaceuticals Limited IPO has a good manufacturing base with over fifteen modem plants in various parts of India. These facilities use the most modern equipment and function under strict quality conditions in the manufacture of its pharmaceutical products. It owns all the abilities in the manufacturing of all forms of preparations like tablets, capsules, syrups, ointments and so on. Currently, its products are featured in many therapeutic classes including cardiovascular, diabetes/ endocrinology, infection/ virology, inflammation/ musculoskeletal and others. Akums Drugs and Pharmaceuticals Limited IPO has sound research and development facilities when it comes to producing value added and efficient drugs. This has been evidenced by current and new product that the company has put in the market and others that are in the pipeline.
Tentative Details
| IPO Open Date | Tuesday, July 30, 2024 |
| IPO Close Date | Thursday, August 1, 2024 |
| Basis of Allotment | Friday, August 2, 2024 |
| Initiation of Refunds | Monday, August 5, 2024 |
| Credit of Shares to Demat | Monday, August 5, 2024 |
| Listing Date | Tuesday, August 6, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 1, 2024 |
Financial Details
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 3,516.37 | 3,266.53 | 3,069.05 |
| Revenue | 4,212.21 | 3,700.93 | 3,694.52 |
| Profit After Tax | 0.79 | 97.82 | -250.87 |
| Net Worth | 709.50 | 717.19 | 621.98 |
| Reserves and Surplus | 861.01 | 868.70 | 787.79 |
| Total Borrowing | 491.56 | 536.97 | 357.95 |
| Amount in ₹ Crore | |||
Promoter Holding
Sanjeev Jain, Sandeep Jain, and Akums Master Trust are the company’s promoters.
| Share Holding Pre-Issue | 84.94% |
| Share Holding Post Issue |
Risks and Challenges
Regulatory Risks
If Akums fails to comply or if rules change, it could affect how the company works and sells its products. The company needs to stay alert and take action to meet these requirements.
Market Competition
Akums goes up against both local and foreign manufacturers. To stay ahead, the company must keep putting money into new technology fresh ideas, and top-notch quality.
Supply Chain
Problems getting raw materials or moving goods around could affect how much Akums can make and when they can deliver. The company needs strong plans to handle their supply chain to lower these risks.
Conclusion
Akums Drugs and Pharmaceuticals Limited’s IPO signals a big step in the company’s growth plans. The firm holds a strong position in the market, offers many products, and shows good financial results. This puts Akums in a great spot to grab more chances in the drug-making industry. The money from the IPO will help the company boost its production, put cash into new ideas, and look into new markets. People who want to invest can join in on the success of a top drug maker with a proven history. But like any investment, it’s key to look at the risks and possible gains before jumping in. In the end, the Akums IPO is shaping up to be a big deal in India’s drug sector. It shows what the company hopes to achieve and how it might grow in the future.
How to apply Akums Drugs and Pharmaceuticals Limited IPO?
STEPS to login in Zerodha Console
Step 1: Go-to the console page of zerodha. Then Click on log in to your account Enter this Zerodha user ID, password and PIN access your account.
Step 2: Go to the IPO Segment
Step 3: Visit the ‘Portfolio’: After login click on Portfolio tab, available at left side menu.
Step 4: IPO search Click on ‘IPO’ which is under the tab of Portfolio to view a list comprising all active IPOs.
Step 5: Click on the Akums Drugs and Pharmaceuticals Limited IPO
Search the IPO: You can filter by Akums Drugs and Pharmaceuticals Limited IPO and search from a list of available public offerings.
Finally, click on ‘Apply’: Upon finding Akums Drugs and Pharmaceuticals Limited IPO you just need to select Apply (along with Submit after entering the input details).
Step 6: Type your Application Details
In the application form, you have to enter your UPI ID: Enter Your UPI Id Once added the UPI ID, it can link to a bank account which have enough balance for applying.
Bid Quantity: Qty Enter Number of shares Qty up to Bid Price, Integer only Click on the option ‘Cut-off’ to apply at cut-off price.
Check your field details: Review All the accurate information entered
Step 7: Apply for the position
Submission: After filling all these opportunities click on the submit button as shown below.
UPI Mandate: There you will get a UPI mandate request in your UPI app. Open the app and confirm the mandate to withhold funds for IPO application
Step 8: Trust the Process
Verify the status: After you have accepted a UPI mandate, your IPO application will be submitted successfully Processed Petition available in the IPO tab under Order Book.